These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 38471092)
1. Community Health Care Providers' Perspectives on Human Immunodeficiency Virus Pre-Exposure Prophylaxis Use Among Black Women in Eastern Virginia. Pitchford K; Shangani S; Dawson C; Masa R; Heron K AIDS Patient Care STDS; 2024 Mar; 38(3):123-133. PubMed ID: 38471092 [TBL] [Abstract][Full Text] [Related]
2. Increasing providers' PrEP prescription for Black cisgender women: A qualitative study to improve provider knowledge and competency via PrEP training. Kasal N; Devlin S; Johnson AK; Dawdani A; Enaholo OE; Liegeon G; Pyra M; Hirschhorn LR; Haider S; Ducheny K; Simon J; Ridgway JP Womens Health (Lond); 2024; 20():17455057241277974. PubMed ID: 39245949 [TBL] [Abstract][Full Text] [Related]
3. Barriers and Facilitators to Acceptability and Uptake of Pre-Exposure Prophylaxis (PrEP) Among Black Women in the United States: a Systematic Review. Smit F; Masvawure TB J Racial Ethn Health Disparities; 2024 Oct; 11(5):2649-2662. PubMed ID: 37531021 [TBL] [Abstract][Full Text] [Related]
4. Risk perception, safer sex practices and PrEP enthusiasm: barriers and facilitators to oral HIV pre-exposure prophylaxis in Black African and Black Caribbean women in the UK. Nakasone SE; Young I; Estcourt CS; Calliste J; Flowers P; Ridgway J; Shahmanesh M Sex Transm Infect; 2020 Aug; 96(5):349-354. PubMed ID: 32532928 [TBL] [Abstract][Full Text] [Related]
5. Barriers and Facilitators to Pre-exposure Prophylaxis Uptake Among Black Women: A Qualitative Analysis Guided by a Socioecological Model. D'Angelo AB; Davis Ewart LN; Koken J; Bimbi D; Brown JT; Grov C J Assoc Nurses AIDS Care; 2021 Jul-Aug 01; 32(4):481-494. PubMed ID: 34171885 [TBL] [Abstract][Full Text] [Related]
6. Perspectives of Black women in the United States on salon-based intervention to promote the uptake of pre-exposure prophylaxis (PrEP) for HIV. Johnson R; Myers D; McKellar M; Saint-Hillaire L; Randolph SD J Clin Nurs; 2021 Nov; 30(21-22):3281-3289. PubMed ID: 33969573 [TBL] [Abstract][Full Text] [Related]
7. Identifying Implementation Strategies to Enhance HIV Pre-Exposure Prophylaxis Uptake Among Black Cisgender Women in New Orleans, Louisiana. Clement ME; Perry B; McKenna K; Beckford J; Davenport T; Murray E; Magee V; Bickham JN; Siren J; Smith A; Lillis R; Corneli A AIDS Patient Care STDS; 2024 Mar; 38(3):144-150. PubMed ID: 38471093 [TBL] [Abstract][Full Text] [Related]
8. Let Me Prep You to PREP Me: Amplifying the Voices of Black Women and Their Providers to Consider PrEP as an HIV Prevention Option. Chandler R; Guillaume D; Wells J; Hernandez N Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162438 [TBL] [Abstract][Full Text] [Related]
9. Adapting Provider Training and Pre-Exposure Prophylaxis Advertising to Increase Pre-Exposure Prophylaxis Awareness and Uptake Among Black Cisgender Women. Devlin SA; Ridgway JP; Dawdani A; Enaholo OE; Liegeon G; Kasal N; Pyra M; Hirschhorn LR; Simon J; Haider S; Ducheny K; Johnson AK AIDS Patient Care STDS; 2023 Dec; 37(12):574-582. PubMed ID: 38011350 [TBL] [Abstract][Full Text] [Related]
10. Community perspectives on addressing and responding to HIV-testing, pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) among African, Caribbean and Black (ACB) people in Ontario, Canada. Etowa J; Tharao W; Mbuagbaw L; Baidoobonso S; Hyman I; Obiorah S; Aden M; Etowa EB; Gebremeskel A; Kihembo M; Nelson L; Husbands W BMC Public Health; 2022 May; 22(1):913. PubMed ID: 35525946 [TBL] [Abstract][Full Text] [Related]
11. Dismantling Barriers and Transforming the Future of Pre-Exposure Prophylaxis Uptake in Young Black and Latinx Sexual Minority Men and Transgender Women. Shorrock F; Alvarenga A; Hailey-Fair K; Vickroy W; Cos T; Kwait J; Trexler C; Wirtz AL; Galai N; Beyrer C; Celentano D; Arrington-Sanders R AIDS Patient Care STDS; 2022 May; 36(5):194-203. PubMed ID: 35507322 [TBL] [Abstract][Full Text] [Related]
12. Multilevel Barriers to HIV PrEP Uptake and Adherence Among Black and Hispanic/Latinx Transgender Women in Southern California. Ogunbajo A; Storholm ED; Ober AJ; Bogart LM; Reback CJ; Flynn R; Lyman P; Morris S AIDS Behav; 2021 Jul; 25(7):2301-2315. PubMed ID: 33515132 [TBL] [Abstract][Full Text] [Related]
13. Facilitators of PrEP Persistence among Black and Latinx Transgender Women in a PrEP Demonstration Project in Southern California. Storholm ED; Ogunbajo A; Nacht CL; Opalo C; Horvath KJ; Lyman P; Flynn R; Reback CJ; Blumenthal J; Moore DJ; Bolan R; Morris S Behav Med; 2024; 50(1):63-74. PubMed ID: 35993278 [TBL] [Abstract][Full Text] [Related]
14. Lived experiences with pre-exposure prophylaxis uptake and adherence among transgender women in Thailand: a qualitative study. Janamnuaysook R; Guo Y; Yu YJ; Phanuphak N; Kawichai S; MacDonell K; Jupimai T; Rongkavilit C; Wang B Sex Health; 2024 Jan; 21():. PubMed ID: 38219741 [TBL] [Abstract][Full Text] [Related]
15. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya. Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288 [TBL] [Abstract][Full Text] [Related]
16. Barriers and facilitators to pre-exposure prophylaxis uptake among male sex workers in Mexico: an application of the RE-AIM framework. Kadiamada-Ibarra H; Hawley NL; Sosa-Rubí SG; Wilson-Barthes M; Franco RR; Galárraga O BMC Public Health; 2021 Nov; 21(1):2174. PubMed ID: 34837988 [TBL] [Abstract][Full Text] [Related]
17. UPDOs Protective Styles, a Multilevel Intervention to Improve Pre-exposure Prophylaxis Uptake Among Black Cisgender Women: Pretest-Posttest Evaluation. Randolph SD; Johnson R; Jeter E; McGee K; Johnson A J Assoc Nurses AIDS Care; 2023 Sep-Oct 01; 34(5):459-468. PubMed ID: 37651624 [TBL] [Abstract][Full Text] [Related]
18. Women's views on communication with health care providers about pre-exposure prophylaxis (PrEP) for HIV prevention. Jackson GY; Darlington CK; Van Tieu H; Brawner BM; Flores DD; Bannon JA; Davis A; Frye V; Chittamuru D; Gugerty P; Koblin BA; Teitelman AM Cult Health Sex; 2022 May; 24(5):642-656. PubMed ID: 33535887 [TBL] [Abstract][Full Text] [Related]
19. Provider Comfort with Prescribing HIV Pre-Exposure Prophylaxis to Adolescents. Pina P; Taggart T; Sanchez Acosta M; Eweka I; Muñoz-Laboy M; Albritton T AIDS Patient Care STDS; 2021 Oct; 35(10):411-417. PubMed ID: 34623888 [TBL] [Abstract][Full Text] [Related]
20. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]